Date: Thu, 18 Dec 1997 15:02:33 GMT
Server: Apache/1.2.0
Connection: close
Content-Type: text/html

<HTML>
	<HEAD>
		<TITLE>TRC PRESS RELEASE - EQUITY OFFERING</TITLE>
		<META NAME="GENERATOR" CONTENT="GoLive CyberStudio">
		<META HTTP-EQUIV="content-type" CONTENT="text/html;charset=iso-8859-1">
	</HEAD>
	<BODY BGCOLOR="#FFFFFF">
		<CENTER><IMG SRC="trc_banner.gif" WIDTH="432" HEIGHT="144" BORDER="0"><P>
		<A HREF="index.html">HOME</A> | <A HREF="trcnew.html">NEW</A> | <A HREF="trcabout.html">ABOUT</A> | <A HREF="trcloc.html">TRC_ LOCATIONS</A> | <A HREF="trclinks.html">RENAL LINKS</A><B><I><FONT SIZE="6"><BR>
		<BR>
		</FONT></I></B><P>
		<B><I><FONT SIZE="6">PRESS RELEASE<BR>
		<BR>
		</FONT></I></B></CENTER><P>
		<B><I><FONT SIZE="6"></FONT></I></B><TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="471">
			<CAPTION><B><FONT SIZE="2">FOR FURTHER INFORMATION, PLEASE CONTACT:</FONT></B> </CAPTION>
			<TR>
				<TD WIDTH="209"><U><FONT SIZE="2">AT THE COMPANY</FONT></U></TD>
				<TD WIDTH="254"><U><FONT SIZE="2">AT THE FINANCIAL RELATIONS BOARD</FONT></U></TD>
			</TR>

			<TR>
				<TD WIDTH="209" VALIGN="TOP"><FONT SIZE="2">VICTOR M.G. CHALTIEL, CEO<BR>
				OR JOHN E. KING, CFO<BR>
				AT (310) 792-2600</FONT></TD>
				<TD WIDTH="254" VALIGN="TOP"><FONT SIZE="2">DANIEL SAKS, GENERAL INFORMATION<BR>
				MOIRA CONLON, INVESTOR CONTACT<BR>
				STEVEN SEILER, MEDIA CONTACT<BR>
				AT (310) 442-0599<BR>
				KATHY BRUNSON, INVESTOR CONTACT<BR>
				AT (312) 266-7800</FONT></TD>
			</TR>
		</TABLE>
		<P>
		<B><FONT SIZE="4">TOTAL RENAL CARE PRICES EQUITY OFFERING<BR>
		</FONT></B><P>
		<B>TORRANCE, CA, October 31, 1996 -- Total Renal Care Holdings, Inc.
		(NYSE: TRL)</B> today announced it has priced a public offering of 2,500,000
		shares at $39 per share. 2,000,000 shares were sold by selling
		stockholders and 500,000 shares were sold by the Company. Donaldson,
		Lufkin &amp; Jenrette Securities Corporation is the lead underwriter
		of the offering with Merrill Lynch &amp; Co. and UBS Securities LLC
		acting as co-managers.<P>
		Net proceeds from the sale of shares by the Company will be used
		for acquisitions, de novo development and for working capital
		and other corporate purposes. Pending such uses, the Company may
		use such proceeds to reduce the amount under the revolving portion
		of the Company's credit facility. The Company will not receive
		any of the proceeds from the sale of the shares being sold by
		the selling stockholders.<P>
		This offer will be made only by means of a prospectus. Copies
		of the prospectus relating to the offer may be obtained from the
		managing underwriters in New York, N.Y.<P>
		Based in Torrance, Calif., Total Renal Care Holdings, Inc., is
		the third largest provider of integrated dialysis services in
		the U.S. for patients suffering from chronic kidney failure. The
		Company owns and operates high-quality, free-standing kidney dialysis
		centers and home peritoneal dialysis programs in 16 states, Washington,
		DC, and Guam, and also provides high-quality acute hemodialysis
		services to inpatients on behalf of 84 hospitals. TRL has increased
		its number of outpatient dialysis facilities to 128 with 1,876
		stations and provides services to more than 9,800 patients. The
		Company additionally operates ESRD laboratory and pharmacy facilities,
		as well as vascular access management and transplant services
		programs.<P>
		For information on Total Renal Care Holdings, Inc. via facsimile
		at no cost, call 1-800-PRO-INFO and dial company code 039. 
	</BODY>
</HTML>
